Akso Health Group
AHG · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $3 | $3 |
| % Growth | 0% | 13.1% | 0% | – |
| Cost of Goods Sold | $4 | $4 | $3 | $3 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -6% | -6% | 2.8% | 2.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $81 | $81 | $0 | $0 |
| Operating Expenses | $83 | $83 | $0 | $0 |
| Operating Income | -$83 | -$83 | -$0 | -$0 |
| % Margin | -2,113.4% | -2,113.4% | -7.8% | -7.8% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$83 | -$83 | -$0 | -$0 |
| Tax Expense | $15 | $15 | $0 | $0 |
| Net Income | -$67 | -$67 | -$0 | -$0 |
| % Margin | -1,713.4% | -1,713.4% | -8.5% | -8.5% |
| EPS | -0.2 | -0.2 | -0.004 | -0.004 |
| % Growth | 0% | -5,028.2% | 0% | – |
| EPS Diluted | -0.2 | -0.2 | -0.004 | -0.004 |
| Weighted Avg Shares Out | 333 | 333 | 78 | 78 |
| Weighted Avg Shares Out Dil | 337 | 337 | 78 | 78 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$0 | -$0 |
| % Margin | -15.9% | -15.9% | -7.6% | -7.6% |